Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hugh R Barrett

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Metabolism: Clinical and Experimental|September 11, 2021
Unravelling lipoprotein metabolism with stable isotopes: tracing the flowQidi Ying, Dick C Chan, P Hugh R Barrett, et al.
The American Journal of Clinical Nutrition|July 11, 2006
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesityDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Biochimica Et Biophysica Acta|January 24, 2006
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigsJohn R Burnett, Dawn E Telford, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolismDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kineticsDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Clinical Science (London, England : 1979)|May 22, 2009
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndromeTheodore W K Ng, Dick C Chan, P Hugh R Barrett, et al.
Journal of Lipid Research|September 18, 2002
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl estersNica M Borradaile, Linda E de Dreu, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)|April 11, 2008
Apolipoprotein C-III: understanding an emerging cardiovascular risk factorEsther M M Ooi, P Hugh R Barrett, Dick C Chan, et al.
The Annals of Pharmacotherapy|March 28, 2003
Toxicity related to chloroquine treatment of resistant vivax malariaTimothy M E Davis, David A Syed, Kenneth F Ilett, et al.
Clinical Chemistry|August 17, 2004
Lipid disorders and mutations in the APOB geneAmanda J Whitfield, P Hugh R Barrett, Frank M van Bockxmeer, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Metabolism: Clinical and Experimental|September 11, 2021
Unravelling lipoprotein metabolism with stable isotopes: tracing the flowQidi Ying, Dick C Chan, P Hugh R Barrett, et al.
The American Journal of Clinical Nutrition|July 11, 2006
Factorial study of the effect of n-3 fatty acid supplementation and atorvastatin on the kinetics of HDL apolipoproteins A-I and A-II in men with abdominal obesityDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Biochimica Et Biophysica Acta|January 24, 2006
The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigsJohn R Burnett, Dawn E Telford, P Hugh R Barrett, et al.
The Journal of Clinical Endocrinology and Metabolism|November 15, 2007
Plasma apolipoprotein C-III transport in centrally obese men: associations with very low-density lipoprotein apolipoprotein B and high-density lipoprotein apolipoprotein A-I metabolismDick C Chan, Minh N Nguyen, Gerald F Watts, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 18, 2006
Apolipoproteins C-III and A-V as predictors of very-low-density lipoprotein triglyceride and apolipoprotein B-100 kineticsDick C Chan, Gerald F Watts, Minh N Nguyen, et al.
Clinical Science (London, England : 1979)|May 22, 2009
Effect of weight loss on HDL-apoA-II kinetics in the metabolic syndromeTheodore W K Ng, Dick C Chan, P Hugh R Barrett, et al.
Journal of Lipid Research|September 18, 2002
Inhibition of hepatocyte apoB secretion by naringenin: enhanced rapid intracellular degradation independent of reduced microsomal cholesteryl estersNica M Borradaile, Linda E de Dreu, P Hugh R Barrett, et al.
Clinical Science (London, England : 1979)|April 11, 2008
Apolipoprotein C-III: understanding an emerging cardiovascular risk factorEsther M M Ooi, P Hugh R Barrett, Dick C Chan, et al.
The Annals of Pharmacotherapy|March 28, 2003
Toxicity related to chloroquine treatment of resistant vivax malariaTimothy M E Davis, David A Syed, Kenneth F Ilett, et al.
Clinical Chemistry|August 17, 2004
Lipid disorders and mutations in the APOB geneAmanda J Whitfield, P Hugh R Barrett, Frank M van Bockxmeer, et al.
Pageof 15